Список проголосовавших за комментарий " <table class="BriefingDataTable" border="0" cellspacing="0" cellpadding="0"><tr> <td class="articleColumn">Gapping down<p><strong>Gapping down<br/> In reaction to disappointing earnings/guidance</strong>:</p><ul><li><strong>CBK</strong> -16.2%, <strong>TIF</strong> -4.7%, <strong>PLG</strong> -3.9%</li></ul><p><strong>M&A news</strong>:</p><ul><li><strong>NBL</strong> -0.5% (to acquire CWEI for $139 per share)</li></ul><p><strong>Other news</strong>:</p><ul><li><strong>ADHD</strong> -52.6% (reports that the Phase 3 clinical trial of MDX in adults with ADHD missed the primary endpoint)</li><li><strong>GLBS</strong> -26.1% (announced that its previously disclosed private placement/conversion of debt will not occur as planned (previously described on November 28, 2016))</li><li><strong>UEC</strong> -11.9% (confirms underwritten public offering of units of the company at price of $1.50/unit)</li></ul><p><strong>Analyst comments</strong>:</p><ul><li><strong>VOD</strong> -2.7% (downgraded to Hold from Buy at HSBC)</li><li><strong>NVS</strong> -1.6% (downgraded to Hold from Buy at Berenberg)</li><li>C<strong>MG</strong> -1.4% (downgraded to Neutral from Overweight at JP Morgan)</li><li><strong>TWTR</strong> -1.1% (downgraded to Neutral from Buy at UBS)</li><li><strong>NAVI</strong> -1.1% (downgraded to Neutral from Overweight at JP Morgan )</li><li><strong>ING</strong> -1% (downgraded to Neutral from Buy at Goldman)</li></ul></td> </tr></table>"